» Articles » PMID: 36506068

Novel Biomarkers and Therapeutic Approaches for Diabetic Retinopathy and Nephropathy: Recent Progress and Future Perspectives

Overview
Specialty Endocrinology
Date 2022 Dec 12
PMID 36506068
Authors
Affiliations
Soon will be listed here.
Abstract

The global burden due to microvascular complications in patients with diabetes mellitus persists and even increases alarmingly, the intervention and management are now encountering many difficulties and challenges. This paper reviews the recent advancement and progress in novel biomarkers, artificial intelligence technology, therapeutic agents and approaches of diabetic retinopathy and nephropathy, providing more insights into the management of microvascular complications.

Citing Articles

Retinal Biomarkers in Diabetic Retinopathy: From Early Detection to Personalized Treatment.

Chondrozoumakis G, Chatzimichail E, Habra O, Vounotrypidis E, Papanas N, Gatzioufas Z J Clin Med. 2025; 14(4).

PMID: 40004872 PMC: 11856754. DOI: 10.3390/jcm14041343.


Interactive effect of phenylalanine with duration of diabetes on the risk of small vessel disease in Chinese patients with T2DM.

Zheng J, Zhang W, Miao Y, Li X, Luo W, Yang X Front Endocrinol (Lausanne). 2025; 15():1472967.

PMID: 39829954 PMC: 11738608. DOI: 10.3389/fendo.2024.1472967.


Identification of hub genes in the crosstalk between type 2 diabetic nephropathy and obesity according to bioinformatics analysis.

Shi S, Ding K, Chen F, Yang M, Ni L, Wu X Adipocyte. 2024; 13(1):2423723.

PMID: 39526504 PMC: 11556279. DOI: 10.1080/21623945.2024.2423723.


Retinal microcirculation changes in prediabetic patients with short-term increased blood glucose using optical coherence tomography angiography.

Lv B, Zuo H, Li Q, Huang F, Zhang T, Huang R World J Radiol. 2024; 16(9):407-417.

PMID: 39355394 PMC: 11440280. DOI: 10.4329/wjr.v16.i9.407.


Exploring the role of Müller cells-derived exosomes in diabetic retinopathy.

Gad M, Elsherbiny N, El-Bassouny D, Omar N, Mahmoud S, Al-Shabrawey M Microvasc Res. 2024; 154:104695.

PMID: 38723843 PMC: 11180575. DOI: 10.1016/j.mvr.2024.104695.


References
1.
Romero-Aroca P, Baget-Bernaldiz M, Navarro-Gil R, Moreno-Ribas A, Valls-Mateu A, Sagarra-Alamo R . Glomerular Filtration Rate and/or Ratio of Urine Albumin to Creatinine as Markers for Diabetic Retinopathy: A Ten-Year Follow-Up Study. J Diabetes Res. 2018; 2018:5637130. PMC: 5846354. DOI: 10.1155/2018/5637130. View

2.
Yildirim Z, Nayir A, Yilmaz A, Gedikbasi A, Bundak R . Neutrophil Gelatinase-Associated Lipocalin as an Early Sign of Diabetic Kidney Injury in Children. J Clin Res Pediatr Endocrinol. 2016; 7(4):274-9. PMC: 4805223. DOI: 10.4274/jcrpe.2002. View

3.
Panchapakesan U, Pollock C . The Role of Dipeptidyl Peptidase - 4 Inhibitors in Diabetic Kidney Disease. Front Immunol. 2015; 6:443. PMC: 4551869. DOI: 10.3389/fimmu.2015.00443. View

4.
Mitchell P, Bandello F, Schmidt-Erfurth U, Lang G, Massin P, Schlingemann R . The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011; 118(4):615-25. DOI: 10.1016/j.ophtha.2011.01.031. View

5.
Ang W, Zunaina E, Norfadzillah A, Raja-Norliza R, Julieana M, Ab-Hamid S . Evaluation of vascular endothelial growth factor levels in tears and serum among diabetic patients. PLoS One. 2019; 14(8):e0221481. PMC: 6705830. DOI: 10.1371/journal.pone.0221481. View